See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

Caesar Yaro

Caesar Yaro

Caesar Yaro

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

A1C

Page 4
UK Study Casts Doubt on Testosterone Therapy for Depressed Type 2s
Sep 18, 2012 | 
A British study of type 2 men reports that although testosterone therapy had a beneficial effect on blood glucose levels and other metabolic indicators for non-depressed men, those suffering from depression experienced no benefit. In fact, reports Geoffrey Hackett, MD, at Good Hope Hospital in Sutton Coldfield, depressed men actually experienced a worsening of symptoms.
Type 2: Intense Control May Raise Hip Fracture Risk
Aug 30, 2012 | 
Older type 2s who exercise tight control over their blood sugar may run an increased risk of hip fracture, says a study from Changi General Hospital in Singapore. The researchers studied 558 elderly people with diabetes who had been treated for hip fracture between 2005 and 2010. They found that those patients had a significantly lower median A1C, 6.8%, than the control group median of 7.4%. In 59.2 percent of the hip fracture cases, the patient's A1C was less than 7%, and slightly more than three-quarters of the patients were taking sulfonylureas.
DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

Caesar Yaro

Caesar Yaro

Caesar Yaro

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

The New Accu-Chek Nano Blood Glucose Meter
Aug 21, 2012 | 
The new Accu-Chek Nano was approved for diabetes patients in January 2012, and distribution of the product began in April. Jennifer Aspy, the director of product marketing and operations, sat down with me at the American Association of Diabetes Educators to talk about the merits of this new medical device.
An Interview With Robert Cuddihy, MD, of Sanofi US
Aug 13, 2012 | 
Endocrinologist Robert Cuddihy, MD, joined Sanofi US over a year ago to be the company’s Vice President and Medical Diabetes Head in the United States. He is responsible for developing and executing the US strategy for Sanofi’s Diabetes Division, including pharmaceuticals, devices, and other technologies. He previously served as the medical director for several organizations, including the International Diabetes Center-Park Nicollet in Minnesota.
A Reckless Summer
Aug 2, 2012 | 
As teenagers, most of us did some reckless and irresponsible things. It's part of growing up, right? But if you're a teenager with type 1 diabetes, acting reckless becomes a bit more tricky. I had a reckless summer of my own ten years ago, right after high school graduation, when I traveled down south to spend a month with my mom. I hadn't lived with her since the age of 16, so I wanted to get to know her and my younger brother again. Unfortunately, I also used that time to take a break from my diabetes regimen. It had been only four years since my diagnosis, and I wanted to feel that even though I had a disease, I was still a normal teenager who was capable of an adventure.
Type 2: Swedes Say a Small Drop in A1C Reduces Risk of Cardiac Death
Jul 29, 2012 | 
Swedish researchers report that a drop in A1C of less than one percentage point can lower the risk of death from cardiovascular disease among people with diabetes by nearly half. Specifically, they found that patients who reduced their A1C from 7.8% to 7.0% decreased their risk of dying from cardiovascular disease by 45 percent.
Type 2: Early Therapy Helps Retain Beta Cell Function
Jul 18, 2012 | 
Immediately starting intense therapy for newly diagnosed type 2s preserved their beta cell functioning for 3.5 years, according to a University of Texas Southwestern Medical Center study.
Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.